Back
Aptevo Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
APVO
Aptevo Therapeutics
Last Price:
$4.97
Seasonality Move:
-31.63%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight buying pressure.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.36 | Buy |
| 20-day SMA: | 7.57 | Sell |
| 50-day SMA: | 8.69 | Sell |
| 200-day SMA: | 30.8 | Sell |
| 8-day EMA: | 5.09 | Sell |
| 20-day EMA: | 6.67 | Sell |
| 50-day EMA: | 8.39 | Sell |
| 200-day EMA: | 165.73 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.44 | Sell |
| Relative Strength Index (14 RSI): | 37.77 | Sell |
| Chaikin Money Flow: | 16593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.23 - 11.09) | Sell |
| Bollinger Bands (100): | (6.33 - 13.21) | Sell |
Aptevo Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 4.84 while APVO 8-day simple moving average is 4.36, which is a Buy signal.
-
The stock price of APVO is 4.84 while Aptevo Therapeutics 20-day SMA is 7.57, which makes it a Sell.
-
Aptevo Therapeutics 50-day simple moving average is 8.69 while APVO share price is 4.84, making it a Sell technically.
-
APVO stock price is 4.84 and Aptevo Therapeutics 200-day simple moving average is 30.80, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
33
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a SellThe current Aptevo Therapeutics [APVO] share price is $4.84. The Score for APVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
2.4M
Price in USD:
4.84
Share Volume:
55.8K
Aptevo Therapeutics 52-Week Range
52-Week High:
399.60
52-Week Low:
3.65
Sell
33
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?The Aptevo Therapeutics stock price is 4.84 USD today.
-
Will APVO stock go up or go down?Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aptevo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 4.84 while APVO 8-day exponential moving average is 5.09, which is a Sell signal.
-
The stock price of APVO is 4.84 while Aptevo Therapeutics 20-day EMA is 6.67, which makes it a Sell.
-
Aptevo Therapeutics 50-day exponential moving average is 8.39 while APVO share price is 4.84, making it a Sell technically.
-
APVO stock price is 4.84 and Aptevo Therapeutics 200-day simple moving average is 165.73, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $17.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,536.34 per share, and an increase next year of $71.15 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
-
APVO Moving Average Covergence Divergence (MACD) indicator is -1.44, suggesting Aptevo Therapeutics is a Sell
-
Aptevo Therapeutics Relative Strength Index (RSI) is 37.77, which suggest Aptevo Therapeutics is oversold
-
The Bollinger Bands (25) for Aptevo Therapeutics is (5.23 - 11.09), which suggest Aptevo Therapeutics is a Sell
-
The Bollinger Bands (100) for Aptevo Therapeutics is (6.33 - 13.21), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.